Losers: RAPT Therapeutics (RAPT) -66% announces clinical hold on studies evaluating Zelnecirnon. Universe Pharmaceuticals (UPC) -31%. FLJ Group Ltd (FLJ) -23%. Tarena International (TCTM) -21% changes...
Source LinkLosers: RAPT Therapeutics (RAPT) -66% announces clinical hold on studies evaluating Zelnecirnon. Universe Pharmaceuticals (UPC) -31%. FLJ Group Ltd (FLJ) -23%. Tarena International (TCTM) -21% changes...
Source Link
Comments